The impact of abrocitinib on vaccine-induced immune responses in adolescents with moderate-to-severe atopic dermatitis undergoing routine tetanus, diphtheria, and pertussis vaccination in phase 3 JADE TEEN

被引：0
|
作者：
Cork, Michael
Eichenfield, Lawrence
Flohr, Carsten
Bangert, Christine
Barbarot, Sebastien
Rojo, Ricardo
Chan, Gary
Zhang, Fan
Feeney, Claire
Valdez, Hernan
机构：
来源：
ALLERGY AND ASTHMA PROCEEDINGS | 2024年 / 45卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 33 条
  • [31] Dupilumab Provides Clinically Meaningful Responses Versus Placebo: A Post Hoc Analysis of a Phase 3 Trial in Adolescents With Moderate-to-Severe Atopic Dermatitis not Achieving an Investigator's Global Assessment Score of 0/1
    Simpson, Eric
    Boguniewicz, Mark
    Blauvelt, Andrew
    Guttman-Yassky, Emma
    Bansal, Ashish
    Chen, Zhen
    Rossi, Ana B.
    Eckert, Laurent
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 23 - 23
  • [32] DUPILUMAB PROVIDES EARLY AND SUSTAINED CLINICALLY MEANINGFUL RESPONSES IN A PHASE 3 TRIAL IN ADOLESCENTS WITH INADEQUATELYCONTROLLED MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM THE OVERALL POPULATION AND IN A SUBGROUP OF PATIENTS NOT ACHIEVING IGA SCORES OF 0/1
    Simpson, Eric L.
    Blauvelt, Andrew
    Guttman-Yassky, Emma
    Gooderham, Melinda
    Hussain, Iftikhar
    Chen, Zhen
    Levit, Noah A.
    Chao, Jingdong
    Rossi, Ana B.
    Bansal, Ashish
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 54 - 54
  • [33] Dupilumab provides early and sustained clinically meaningful responses in a phase 3 trial in adolescents with inadequately controlled moderate-to-severe atopic dermatitis: Results from the overall population and in a subgroup of patients not achieving IGA scores of 0/1
    Simpson, Eric L.
    Blauvelt, Andrew
    Guttman-Yassky, Emma
    Gooderham, Melinda
    Hussain, Iftikhar
    Chen, Zhen
    Levit, Noah A.
    Rossi, Ana B.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (01) : 89 - 89
1234